The Chemours Company
CC · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $6 | $6 | $7 | $6 |
| % Growth | -4.9% | -11% | 7.7% | – |
| Cost of Goods Sold | $5 | $5 | $5 | $5 |
| Gross Profit | $1 | $1 | $2 | $1 |
| % Margin | 19.9% | 21.5% | 23.7% | 21.8% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $1 | $1 | $1 | $1 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $1 | $1 | $1 | $1 |
| Operating Income | $0 | -$0 | $1 | $1 |
| % Margin | 7.7% | -2% | 11.5% | 10.6% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | $0 |
| Pre-Tax Income | $0 | -$0 | $1 | $1 |
| Tax Expense | $0 | -$0 | $0 | $0 |
| Net Income | $0 | -$0 | $1 | $1 |
| % Margin | 1.5% | -3.9% | 8.5% | 9.6% |
| EPS | 0.58 | -1.6 | 3.72 | 3.69 |
| % Growth | 136.3% | -143% | 0.8% | – |
| EPS Diluted | 0.57 | -1.6 | 3.65 | 3.6 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $1 | $0 | $1 | $1 |
| % Margin | 12% | 3.2% | 17.5% | 18.6% |